These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 22854290)
21. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI). Dewint P; Hansen BE; Verhey E; Oldenburg B; Hommes DW; Pierik M; Ponsioen CI; van Dullemen HM; Russel M; van Bodegraven AA; van der Woude CJ Gut; 2014 Feb; 63(2):292-9. PubMed ID: 23525574 [TBL] [Abstract][Full Text] [Related]
22. Crohn's-like disease in a patient with common variable immunodeficiency treated with azathioprine and adalimumab. Vázquez-Morón JM; Pallarés-Manrique H; Martín-Suárez IJ; Benítez-Rodríguez B; Ramos-Lora M Rev Esp Enferm Dig; 2013; 105(5):299-302. PubMed ID: 23971663 [TBL] [Abstract][Full Text] [Related]
23. Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease. Watanabe M; Hibi T; Mostafa NM; Chao J; Arora V; Camez A; Petersson J; Thakkar R J Crohns Colitis; 2014 Nov; 8(11):1407-16. PubMed ID: 24874893 [TBL] [Abstract][Full Text] [Related]
24. [The use of adalimumab in severe fistulising Crohn's disease]. Bang UC; Nielsen AM Ugeskr Laeger; 2008 Jun; 170(25):2256. PubMed ID: 18565318 [TBL] [Abstract][Full Text] [Related]
25. [The cost effectiveness of adalimumab in Crohn's disease (review of foreign pharmacoeconomic studies)]. Rudakova AV Eksp Klin Gastroenterol; 2011; (9):113-9. PubMed ID: 22629787 [No Abstract] [Full Text] [Related]
26. Successfully multiple pregnancies in Crohn's disease under long-term treatment with adalimumab. Tursi A Acta Gastroenterol Belg; 2013 Jun; 76(2):264-5. PubMed ID: 23898572 [No Abstract] [Full Text] [Related]
27. Adalimumab for the treatment of pediatric Crohn's disease. Nuti F; Fiorino G; Danese S Expert Rev Clin Immunol; 2015; 11(9):963-72. PubMed ID: 26211396 [TBL] [Abstract][Full Text] [Related]
28. Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: results from the CARE trial. Louis E; Löfberg R; Reinisch W; Camez A; Yang M; Pollack PF; Chen N; Chao J; Mulani PM J Crohns Colitis; 2013 Feb; 7(1):34-43. PubMed ID: 22480772 [TBL] [Abstract][Full Text] [Related]
29. A case of opportunistic skin infection with Mycobacterium marinum during adalimumab treatment in a patient with Crohn's disease. Kump PK; Högenauer C; Wenzl HH; Petritsch W J Crohns Colitis; 2013 Feb; 7(1):e15-8. PubMed ID: 22770648 [TBL] [Abstract][Full Text] [Related]
30. Risk of permanent stoma in extensive Crohn's colitis: the impact of biological drugs. Coscia M; Gentilini L; Laureti S; Gionchetti P; Rizzello F; Campieri M; Calabrese C; Poggioli G Colorectal Dis; 2013 Sep; 15(9):1115-22. PubMed ID: 23594132 [TBL] [Abstract][Full Text] [Related]
31. Adalimumab for the prevention of recurrence after surgery for Crohn's disease. Yamamoto T Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):863; author reply 863-4. PubMed ID: 22668832 [No Abstract] [Full Text] [Related]
32. Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience. Sprakes MB; Hamlin PJ; Warren L; Greer D; Ford AC J Crohns Colitis; 2011 Aug; 5(4):324-31. PubMed ID: 21683302 [TBL] [Abstract][Full Text] [Related]
33. Gastrocolic fistulization in Crohn's disease: a case report and a review of the literature. Khanna MP; Gordon PH Can J Surg; 2000 Feb; 43(1):53-6. PubMed ID: 10714259 [No Abstract] [Full Text] [Related]
34. Exploring the use of adalimumab for patients with moderate Crohn's disease: subanalyses from induction and maintenance trials. Sandborn WJ; Colombel JF; Panés J; Castillo M; Robinson AM; Zhou Q; Yang M; Thakkar R J Crohns Colitis; 2013 Dec; 7(12):958-67. PubMed ID: 23517933 [TBL] [Abstract][Full Text] [Related]